Cancers 2010, 2(4), 2058-2083; doi:10.3390/cancers2042058

Epithelial-Mesenchymal Transition in Pancreatic Carcinoma

1,* email, 1,†email and 2,†email
Received: 9 November 2010; in revised form: 1 December 2010 / Accepted: 1 December 2010 / Published: 9 December 2010
(This article belongs to the Special Issue Pancreatic Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Pancreatic carcinoma is the fourth-leading cause of cancer death and is characterized by early invasion and metastasis. The developmental program of epithelial-mesenchymal transition (EMT) is of potential importance for this rapid tumor progression. During EMT, tumor cells lose their epithelial characteristics and gain properties of mesenchymal cells, such as enhanced motility and invasive features. This review will discuss recent findings pertinent to EMT in pancreatic carcinoma. Evidence for and molecular characteristics of EMT in pancreatic carcinoma will be outlined, as well as the connection of EMT to related topics, e.g., cancer stem cells and drug resistance.
Keywords: pancreatic adenocarcinoma; epithelial-mesenchymal transition; tumor progression; cancer stem cells; chemoresistance
PDF Full-text Download PDF Full-Text [454 KB, uploaded 9 December 2010 12:44 CET]

Export to BibTeX |

MDPI and ACS Style

Maier, H.J.; Wirth, T.; Beug, H. Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers 2010, 2, 2058-2083.

AMA Style

Maier HJ, Wirth T, Beug H. Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers. 2010; 2(4):2058-2083.

Chicago/Turabian Style

Maier, Harald J.; Wirth, Thomas; Beug, Hartmut. 2010. "Epithelial-Mesenchymal Transition in Pancreatic Carcinoma." Cancers 2, no. 4: 2058-2083.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert